Feb 25, 2026 09:07AM
Feb 25, 2026 09:00AM
Jan 15, 2026 09:00AM
Jan 15, 2026 09:00AM
Jan 12, 2026 09:01AM
Jan 12, 2026 09:00AM
Dec 23, 2025 04:05PM CASI Pharmaceuticals gets Nasdaq extension until February 17, 2026
Dec 23, 2025 04:05PM
Dec 11, 2025 09:01AM
Dec 11, 2025 09:00AM
Dec 8, 2025 09:02AM
Dec 8, 2025 09:00AM
Nov 19, 2025 09:00AM
Nov 14, 2025 05:46PM CASI Pharma (CASI) Misses Q3 EPS by 67c
Nov 14, 2025 04:05PM
Nov 10, 2025 04:06PM
Nov 10, 2025 04:05PM
Nov 4, 2025 09:00AM
Nov 3, 2025 09:01AM
Sep 26, 2025 09:47AM
Sep 26, 2025 09:45AM CASI Pharmaceuticals Appoints James Huang to Board of Directors
Sep 8, 2025 09:00AM
Sep 8, 2025 09:00AM
Sep 3, 2025 09:00AM
Sep 2, 2025 09:00AM
Sep 2, 2025 09:00AM
Aug 29, 2025 04:05PM
Aug 28, 2025 09:00AM CASI Pharmaceuticals to Participate at Cantor Global Healthcare Conference 2025
Aug 4, 2025 09:01AM
Aug 4, 2025 09:00AM
Jul 21, 2025 04:06PM
Jul 21, 2025 04:05PM
May 19, 2025 09:00AM
May 16, 2025 08:00AM
May 12, 2025 08:03AM CASI Pharma (CASI) to Divest Assets in China
May 12, 2025 08:00AM
May 7, 2025 08:03AM
May 7, 2025 08:00AM
Apr 3, 2025 08:07AM
Apr 3, 2025 08:00AM
Mar 31, 2025 08:15AM
Jan 6, 2025 08:00AM CASI Announces First Patient Dosed in Phase 1/2 Clinical Trial of CID-103 in Immune Thrombocytopenia
Nov 15, 2024 08:00AM
Oct 24, 2024 08:03AM
Oct 24, 2024 08:00AM
Aug 16, 2024 12:43PM
Jul 8, 2024 07:34AM
Jun 26, 2024 04:56PM
Jun 26, 2024 04:17PM CASI Pharma (CASI) To Submit IND Application For CID-103, Announces Receipt of Non-Binding Proposal to Acquire Entire China Business
Jun 26, 2024 04:11PM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All